why is semaglutide more expensive than tirzepatide vs. cost Tirzepatide vs semaglutide dosage chart:

Eligibility for clinical trials typically requires: BMI of 30 or greater, or BMI of 27 or greater with weight-related comorbidities No recent use of other weight loss medications (washout periods apply) Willingness to attend regular study visits and follow protocols Meeting specific inclusion/exclusion criteria that vary by trial Compounding Pharmacies Some compounding pharmacies have begun offering retatrutide

It states plainly that compounded semaglutide is not the same product as branded Ozempic or Wegovy, which are mass-manufactured and FDA-approved

Tirzepatide, a dual GIP/GLP-1 agonist, produces somewhat larger weight reductions in clinical trialsaveraging 22% versus 15% for semaglutidewhich might translate to slightly greater blood pressure benefits in individual patients

Following discontinuation of tirzepatide, CIR-0602K reduces weight rebound, consistent with the beneficial metabolic effects seen in muscle and adipose